logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Journal Article
|Research

Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa

Lawn SD, Campbell L, Kaplan R, Boulle AM, Cornell M, Kerschberger B, Morrow C, Little F, Egger M, Wood R
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
We studied the time interval between starting tuberculosis treatment and commencing antiretroviral treatment (ART) in HIV-infected patients (n = 1433; median CD4 count 71 cells per microliter, interquartile range: 32-132) attending 3 South African township ART services between 2002 and 2008. The overall median delay was 2.66 months (interquartile range: 1.58-4.17). In adjusted analyses, delays varied between treatment sites but were shorter for patients with lower CD4 counts and those treated in more recent calendar years. During the most recent period (2007-2008), 4.7%, 19.7%, and 51.1% of patients started ART within 2, 4, and 8 weeks of tuberculosis treatment, respectively. Operational barriers must be tackled to permit further acceleration of ART initiation as recommended by 2010 WHO ART guidelines.

Countries

South Africa

Subject Area

tuberculosisHIV/AIDSaccess to health care

Languages

English
DOI
10.1097/QAI.0b013e3182199ee9
Published Date
01 Jun 2011
PubMed ID
21436714
Journal
Journal of Acquired Immune Deficiency Syndromes (1999)
Volume | Issue | Pages
Volume 57, Issue 2
Issue Date
2011-06-01
Dimensions Badge
Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa | Journal Article / Research | MSF Science Portal